Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
Kuiper BI, Abu Hilal M, Aldrighetti LA, Björnsson B, D'Hondt M, Dopazo C, Fretland ÅA, Isoniemi H, Philip Jonas J, Kazemier G, Lesurtel M, Primrose J, Schnitzbauer AA, Buffart T, Gruenberger B, Swijnenburg RJ, Gruenberger T. Kuiper BI, et al. Among authors: gruenberger t. HPB (Oxford). 2024 May;26(5):639-647. doi: 10.1016/j.hpb.2024.01.007. Epub 2024 Jan 29. HPB (Oxford). 2024. PMID: 38373870 Free article.
Neoadjuvant therapy with bevacizumab.
Gruenberger T, Gruenberger B, Scheithauer W. Gruenberger T, et al. Among authors: gruenberger b. J Clin Oncol. 2006 Jun 1;24(16):2592-3; author reply 2593-4. doi: 10.1200/JCO.2005.05.2910. J Clin Oncol. 2006. PMID: 16735714 No abstract available.
Selective resection of colorectal liver metastases.
Tamandl D, Gruenberger B, Herberger B, Schoppmann S, Bodingbauer M, Schindl M, Puhalla H, Fleischmann E, Schima W, Jakesz R, Laengle F, Gruenberger T. Tamandl D, et al. Among authors: gruenberger t, gruenberger b. Eur J Surg Oncol. 2007 Mar;33(2):174-82. doi: 10.1016/j.ejso.2006.09.008. Epub 2006 Oct 12. Eur J Surg Oncol. 2007. PMID: 17046194
Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.
Klinger M, Eipeldauer S, Hacker S, Herberger B, Tamandl D, Dorfmeister M, Koelblinger C, Gruenberger B, Gruenberger T. Klinger M, et al. Among authors: gruenberger t, gruenberger b. Eur J Surg Oncol. 2009 May;35(5):515-20. doi: 10.1016/j.ejso.2008.12.013. Epub 2009 Feb 5. Eur J Surg Oncol. 2009. PMID: 19200687
151 results